Planet 13 Holdings (PLNH) Capital Expenditures (2021 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Capital Expenditures of $665171.0 for Q1 2026, down 75.28% year-over-year from $2.7 million in Q1 2025, and down 11.99% quarter-over-quarter from $755761.0 in Q4 2025.
Planet 13 Holdings (PLNH) Capital Expenditures (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Capital Expenditures for 6 consecutive years, with $665171.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures fell 75.28% year-over-year to $665171.0; the TTM figure through Mar 2026 stood at $4.5 million (down 61.44% YoY), while the FY2025 annual figure was $6.6 million, down 45.44% from the prior year.
- Capital Expenditures declined to $665171.0 in Q1 2026 per PLNH's latest filing, from $755761.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $7.7 million in Q2 2022 and bottomed at $417328.0 in Q2 2023.
- Historically, Capital Expenditures has averaged $2.6 million across 5 years, with a median of $2.5 million in 2024.
- Annual changes were most pronounced in 2023 — Capital Expenditures plunged 94.59% — and 2024, when it surged 875.57%.
- Planet 13 Holdings' Capital Expenditures stood at $2.0 million in 2022, then rose by 15.64% to $2.4 million in 2023, then climbed by 9.04% to $2.6 million in 2024, then tumbled by 70.51% to $755761.0 in 2025, then retreated by 11.99% to $665171.0 in 2026.
- Business Quant data shows PLNH's Capital Expenditures at $665171.0 in Q1 2026, $755761.0 in Q4 2025, and $848734.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Planet 13 Holdings | 54.56 Mn | 38.08 Mn | 12.32 Mn | 423,029.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 423,029.00 |
| Jun 30, 2026 | 423,029.00 |
| Mar 31, 2026 | 665,171.00 |
| Mar 31, 2026 | 665,171.00 |
| Dec 31, 2025 | 755,761.00 |
| Dec 31, 2025 | 755,761.00 |
| Sep 30, 2025 | 848,734.00 |
| Sep 30, 2025 | 848,734.00 |
| Jun 30, 2025 | 2.28 Mn |
| Jun 30, 2025 | 2.28 Mn |
| Mar 31, 2025 | 2.69 Mn |
| Mar 31, 2025 | 2.69 Mn |
| Dec 31, 2024 | 2.56 Mn |
| Dec 31, 2024 | 2.56 Mn |
| Sep 30, 2024 | 2.46 Mn |
| Sep 30, 2024 | 2.46 Mn |
| Jun 30, 2024 | 4.07 Mn |
| Jun 30, 2024 | 4.07 Mn |
| Mar 31, 2024 | 2.95 Mn |
| Mar 31, 2024 | 2.95 Mn |